Forskolin-mediated cAMP activation upregulates TNF-α expression despite NF-κB downregulation in LPS-treated Schwann cells
Main Authors: | Caitlyn Henry, Mackenzie Wilcox, Angela L. Asirvatham |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2024-01-01
|
Series: | PLoS ONE |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11020835/?tool=EBI |
Similar Items
-
Total biosynthesis of the cyclic AMP booster forskolin from Coleus forskohlii
by: Irini Pateraki, et al.
Published: (2017-03-01) -
Correction: Opposing Roles of pka and epac in the cAMP-Dependent Regulation of Schwann Cell Proliferation and Differentiation
Published: (2014-01-01) -
Forskolin, an Adenylcyclase/cAMP/CREB Signaling Activator Restoring Myelin-Associated Oligodendrocyte Destruction in Experimental Ethidium Bromide Model of Multiple Sclerosis
by: Tarun Kapoor, et al.
Published: (2022-09-01) -
Forskolin affects proliferation, migration and Paclitaxel-mediated cytotoxicity in non-small-cell lung cancer cell lines via adenylyl cyclase/cAMP axis
by: Alessia Salzillo, et al.
Published: (2023-06-01) -
Design, synthesis, anti-inflammatory evaluation, and molecular modelling of new coumarin-based analogs combined curcumin and other heterocycles as potential TNF-α production inhibitors via upregulating Nrf2/HO-1, downregulating AKT/mTOR signalling pathways and downregulating NF-κB in LPS induced macrophages
by: Lina M. A. Abdel Ghany, et al.
Published: (2023-12-01)